Genertec Universal Medical Group Co (HKSE:02666) ROCE % : 5.06% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genertec Universal Medical Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genertec Universal Medical Group Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 5.06%.

Genertec Universal Medical Group Co ROCE % Historical Data

The historical data trend for Genertec Universal Medical Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genertec Universal Medical Group Co ROCE % Chart

Genertec Universal Medical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.07

6.40

6.17

5.14

5.71

Genertec Universal Medical Group Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															5.10	5.59	4.50	5.97	5.06

Genertec Universal Medical Group Co ROCE % Calculation

Genertec Universal Medical Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	3177.72	/	( ( (85965.065 - 29550.88)	+	(87879.385 - 32893.695) )	/ 2 )
	=	3177.72	/	( (56414.185	+	54985.69)	/ 2 )
	=	3177.72	/	55699.9375
	=	5.71 %

Genertec Universal Medical Group Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	2898.02	/	( ( (92148.43 - 32678.154)	+	(87879.385 - 32893.695) )	/ 2 )
	=	2898.02	/	( ( 59470.276	+	54985.69 )	/ 2 )
	=	2898.02	/	57227.983
	=	5.06 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Genertec Universal Medical Group Co (HKSE:02666) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genertec Universal Medical Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Genertec Universal Medical Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genertec Universal Medical Group Co (HKSE:02666) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Genertec Universal Medical Group Co Ltd (HKSE:02666) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

5UM:Germany

Address

8-1 Chongwenmenwai Street, 4th, 5th and 13th Floor, West Wing of Hademen Plaza, Dongcheng District, Beijing, CHN

Website

https://www.umcare.cn

Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The Group has two business segments; The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services, and The hospital group business comprises medical services, hospital, and healthcare management, import and export trade, and domestic trade of medical-related goods and life cycle management of equipment assets. Geographically, it derives a majority of its revenue from Mainland China.

Executives

Citic Capital Holdings Limited	2201 Interest of corporation controlled by you
Tong Yong Ji Shu Ji Tuan Xiang Gang Guo Ji Zi Ben You Xian Gong Si	2101 Beneficial owner
Zhong Guo Tong Yong Ji Shu Ji Tuan Kong Gu You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Cp Management Holdings Limited	2201 Interest of corporation controlled by you
Trustar Capital Holdings Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Hopson Technology Holdings Limited	2201 Interest of corporation controlled by you
Sounda Hopson Technology Investment Limited	2201 Interest of corporation controlled by you
Zhang Yichen	2201 Interest of corporation controlled by you
Citic Capital Partners Limited	2201 Interest of corporation controlled by you

Genertec Universal Medical Group Co (HKSE:02666) Headlines

No Headlines